Testing effectiveness (Phase 2)Ended earlyNCT01220258
What this trial is testing
A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
Who this might be right for
Posterior Blepharoconjunctivitis
Merck Sharp & Dohme LLC 29
Showing 8 of 8 results